Answers are grounded in this paper and cite their sources.
Intravenous administration of Tramadol produces higher bioavailability (Cmax and AUClast) of the parent drug and lower of M1, than oral route. Dose normalized Cmax and AUClast of Tramadol and M1 were into the bioequivalence interval. Upon our pharmacokinetics study results, the intravenous dose of Tramadol should not be reduced when switching from oral dosing. No significant differences attributable to sex, once corrected by weight, were found.
No takes yet. Share an insight, caveat, or question.
Portolés-Díez et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: